Abstract
The purpose of this study was to investigate the oxidative damage induced by dietary nickel chloride (NiCl2) in the intestinal mucosa of different parts of the intestine of broilers, including duodenum, jejunum and ileum. A total of 240 one-day-old broilers were divided into four groups and fed on a corn-soybean basal diet as control diet or the same basal diet supplemented with 300, 600 or 900 mg/kg NiCl2 during a 42-day experimental period. The results showed that the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), and the ability to inhibit hydroxy radical and glutathione (GSH) content were significantly (p < 0.05 or p < 0.01) decreased in the 300, 600 and 900 mg/kg groups in comparison with those of the control group. In contrast, malondialdehyde (MDA) content was significantly (p < 0.05 or p < 0.01) higher in the 300, 600 and 900 mg/kg groups than that in the control group. It was concluded that dietary NiCl2 in excess of 300 mg/kg could cause oxidative damage in the intestinal mucosa in broilers, which finally impaired the intestinal functions including absorptive function and mucosal immune function. The oxidative damage might be a main mechanism on the effects of NiCl2 on the intestinal health of broilers.
Keywords: broiler, intestinal mucosa, nickel chloride, oxidative damage
1. Introduction
Nickel (Ni) is a naturally occurring metal element of widespread distribution in the environment and with many industrial and commercial uses. Ni is also a nutritionally essential trace element for many animal species, micro-organisms and plants, and therefore either deficiency or toxicity symptoms can occur when too little or too much Ni is taken up, respectively [1,2,3,4]. Ni forms stable stoichiometric complexes with amino acids [5,6,7], proteins [8] and other organic compounds [9]. Two biological compounds have been found to essentially contain Ni: urease from jack beans [10,11,12] and carbon monoxide dehydrogenase from clostridia [13,14,15].
In 1990 the International Agency for Research on Cancer (IARC) classified Ni compounds as carcinogenic to humans [16]. The adverse effects of Ni on animals following acute, subchronic, and chronic exposure periods can be classified according to their systemic, immunologic, neurologic, reproductive, or developmental aspects [17].
The findings with chicks suggested that Ni may play a role in the function of membranes [18]. Besides the function of nutritional absorption, the intestinal mucosa displays complex defense mechanisms [19]. In relation to prooxidant-antioxidant balance, the intestinal mucosa occupies a unique position [20]. The detection and measurement of lipid peroxidation is most frequently cited to support the involvement of free-radical reactions in toxicology and disease [21]. The antioxidant capacity of the intestinal mucosa is crucial for achieving healthy intestinal function in broilers. As a nutritionally essential trace element, Ni-induced oxidative damage in the intestines of animals has not been reported to date. Ni exposure causes formation of free radicals in various tissues in both human and animals, and enhances lipid peroxidation. Free radical generation from the reaction of Ni-thiol complexes and molecular oxygen, and/or lipid hydroperoxides, can play an important role in the mechanism(s) of Ni toxicity [22]. It has been reported that changes of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and glutathione reductase (GSSG-R) activity, and glutathione (GSH) and malondialdehyde (MDA) contents induced by Ni are observed in the blood, liver or kidney of rats [23]. However, at present there are no reports about the impact of nickel chloride (NiCl2) on the oxidative damage in the intestines (duodenum, jejunum and ileum) of animals. Parameters that were used to represent the oxidative damage in this study included the activities of SOD, CAT and GSH-Px, and ability to inhibit hydroxy radical, and contents of GSH and MDA. The aims were to provide new evidence for further understanding the mechanism about the effects of NiCl2 on intestinal health.
2. Materials and Methods
2.1. Chickens and Diets
240 one-day-old healthy avian broilers were randomly divided by body weight into four groups with 60 broilers in each group. Broilers were housed in cages with electrical heaters and were provided with feed and water as well as undermentioned experimental diets ad libitum for 42 days. A corn-soybean basal diet formulated by the National Research Council (NRC) [24] was the control diet. NiCl2 was mixed into the corn-soybean basal diet to produce the experimental diets containing 300, 600 and 900 mg/kg NiCl2, respectively.
2.2. Detection of Oxidative Damage Parameters in the Intestinal Mucosa
At 14, 28, and 42 days of age during the experiment, five broilers in each group were humanely killed and the intestinal tract were immediately removed and chilled to 0 °C in 0.85% sodium chloride (NaCl) solution, and divided into the duodenum, jejunum and ileum. A segment of approximately 4 cm in length was collected from the middle section of each intestinal region, and then dissected and thoroughly cleaned with 0.85% NaCl solution. The mucosa was carefully scraped from the luminal face of the taken intestinal segments with clean slides and put into 2.5 mL aseptic tubes and then stored at −80 °C prior to the measurement of oxidative damage parameters. For detection, the scraped mucosa was weighed and homogenized in nine volumes of ice-cold 85% NaCl solution in a chilled homogenizer, and immediately centrifuged at 3,000 × g for 10 min at 4 °C. The pellet was discarded and the supernatant was conserved for future analysis [25].
After determining the amount of total protein (A045-2, LOT: 201211) in the supernatant of the mucosa homogenate by the Bradford method [26], the activities of SOD, CAT and GSH-Px, and ability to inhibit hydroxy radical, and contents of MDA and GSH in the supernatant were detected by biochemical methods following the instructions of the corresponding reagent kits (SOD: Cat. No.: A001-1, LOT: 201211; CAT: Cat. No.: A007, LOT: 201211; GSH-Px: Cat. No.: A005, LOT: 201211; ability to inhibit hydroxy radical: Cat. No.: A018, LOT: 201211; MDA: Cat. No.: A003-2, LOT: 201211; GSH: Cat. No.: A006, LOT: 201211, all purchased from Nanjing Jiancheng Bioengineering Institute of China, Nanjing, China). The absorbance of SOD, CAT, GSH-Px, ability to inhibit hydroxy radical, MDA, GSH and total protein were measured at 550, 240, 412, 550, 532, 420 nm and 590 nm, respectively, with a Varioskan Flash microtiter plate reader (Thermo, MA, USA).
2.3. Statistical Analysis
The significance of difference among four groups was analyzed by variance analysis, and results presented as means ± standard deviation (X ± S). The analysis was performed under SPSS 12.0 for windows. A value of p < 0.05 was considered significant.
3. Results
3.1. Changes of the SOD Activities
The SOD activities of duodenum were lower (p < 0.05) in the 300 mg/kg group at 42 days of age and were significantly (p < 0.05 or p < 0.01) lower in the 600 and the 900 mg/kg groups than those in the control group from 14 to 42 days of age. The SOD activities of jejunum and ileum were significantly (p < 0.05 or p < 0.01) decreased in the 300, 600 and 900 mg/kg groups in comparison with those of control group from 14 to 42 days of age (Table 1).
Table 1.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14 Days | Control group | 78.61 ± 3.37 | 68.77 ± 2.86 | 63.60 ± 2.73 |
300 mg/kg group | 76.91 ± 3.60 | 65.60 ± 2.30 | 62.90 ± 2.38 | |
600 mg/kg group | 73.38 ± 4.34 | 67.45 ± 2.80 | 61.72 ± 2.72 | |
900 mg/kg group | 72.16 ± 2.67 * | 63.97 ± 5.51 | 59.52 ± 2.14 * | |
28 Days | Control group | 76.18 ± 4.69 | 67.00 ± 4.37 | 67.76 ± 3.71 |
300 mg/kg group | 72.10 ± 5.06 | 61.66 ± 3.19 * | 62.80 ± 2.85 * | |
600 mg/kg group | 63.24 ± 5.89 ** | 59.33 ± 4.56 ** | 60.62 ± 3.82 ** | |
900 mg/kg group | 63.24 ± 5.89 ** | 52.50 ± 4.31 ** | 59.60 ± 2.05 ** | |
42 Days | Control group | 76.75 ± 4.06 | 66.94 ± 3.49 | 70.90 ± 4.56 |
300 mg/kg group | 69.07 ± 2.29 * | 60.65 ± 4.63 * | 62.73 ± 3.38 ** | |
600 mg/kg group | 63.29 ± 3.28 ** | 58.63 ± 3.23 ** | 61.47 ± 3.08 ** | |
900 mg/kg group | 64.47 ± 6.84 ** | 52.32 ± 3.20 ** | 56.67 ± 3.75 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
3.2. Changes of the CAT Activities
As showed in Table 2, the CAT activities of duodenum, jejunum and ileum were significantly (p < 0.05 or p < 0.01) reduced in the 300, 600 and 900 mg/kg groups when compared with those of the control group from 14 to 42 days of age.
Table 2.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14 Days | Control group | 494.59 ± 14.43 | 467.09 ± 17.61 | 354.34 ± 15.94 |
300 mg/kg group | 492.29 ± 18.40 | 459.79 ± 15.82 | 350.79 ± 25.61 | |
600 mg/kg group | 484.78 ± 23.97 | 457.28 ± 16.31 * | 346.78 ± 16.66 | |
900 mg/kg group | 481.46 ± 17.76 * | 454.79 ± 14.18 * | 343.54 ± 23.89 * | |
28 Days | Control group | 479.96 ± 10.82 | 459.96 ± 10.82 | 348.71 ± 18.33 |
300 mg/kg group | 468.36 ± 23.60 * | 448.36±13.60* | 337.61 ± 15.36 * | |
600 mg/kg group | 467.73 ± 17.34 * | 447.73 ± 27.34 * | 334.73 ± 9.08 * | |
900 mg/kg group | 460.43 ± 14.50 ** | 440.43 ± 14.50 ** | 330.43 ± 14.50 ** | |
42 Days | Control group | 470.29 ± 10.04 | 455.29 ± 15.20 | 345.79 ± 16.43 |
300 mg/kg group | 454.18 ± 14.32 ** | 441.68 ± 13.75 ** | 331.18 ± 24.27 ** | |
600 mg/kg group | 452.56 ± 23.24 ** | 437.56 ± 18.80 ** | 326.06 ± 19.22 ** | |
900 mg/kg group | 445.75 ± 15.68 ** | 428.25 ± 22.79 ** | 317.75 ± 13.53 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
3.3. Changes of the GSH-Px Activities
The duodenal and ileac GSH-Px activities were significantly (p < 0.05 or p < 0.01) decreased in the 300, 600 and 900 mg/kg groups in comparison with those of control group from 14 to 42 days of age. The GSH-Px activities of jejunum were lower (p < 0.05) in the 300 mg/kg group at 42 days and were significantly (p < 0.05 or p < 0.01) lower in the 600 and the 900 mg/kg groups than those in the control group from 28 to 42 days of age (Table 3).
Table 3.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14 Days | Control group | 427.83 ± 26.22 | 453.03 ± 50.07 | 330.44 ± 11.33 |
300 mg/kg group | 403.37 ± 24.81 | 419.59 ± 34.27 | 301.11 ± 41.15 | |
600 mg/kg group | 372.82 ± 41.02 * | 410.53 ± 27.16 | 289.89 ± 39.75 | |
900 mg/kg group | 367.35 ± 34.10 * | 404.86 ± 48.18 | 271.08 ± 36.61 * | |
28 Days | Control group | 485.80 ± 24.83 | 422.94 ± 29.34 | 351.25 ± 26.56 |
300 mg/kg group | 432.76 ± 28.56 * | 408.76 ± 39.64 | 311.25 ± 12.57 * | |
600 mg/kg group | 387.15 ± 38.39 ** | 367.17 ± 22.39 * | 302.67 ± 21.87 * | |
900 mg/kg group | 355.06 ± 39.78 ** | 369.78 ± 26.99 * | 257.06 ± 27.08 ** | |
42 Days | Control group | 431.78 ± 31.36 | 394.57 ± 15.91 | 351.91 ± 14.85 |
300 mg/kg group | 378.48 ± 11.26 ** | 340.17 ± 32.96 * | 323.75 ± 4.59 ** | |
600 mg/kg group | 358.28 ± 12.68 ** | 354.04 ± 23.11 * | 315.49 ± 17.34 ** | |
900 mg/kg group | 340.31 ± 15.21 ** | 336.79 ± 30.07 ** | 300.50 ± 11.05 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
3.4. Changes of the Abilities to Inhibit Hydroxy Radical
The abilities to inhibit hydroxy radical of duodenum and jejunum were significantly (p < 0.05 or p < 0.01) lower in the 300, 600 and 900 mg/kg groups than those in the control group from 14 to 42 days of age.
The ability to inhibit hydroxy radical of ileum was significantly (p < 0.05 or p < 0.01) decreased in the 300, 600 and 900 mg/kg groups from 28 to 42 days of age, and were decreased (p < 0.05) in the 900 mg/kg group at 14 days of age, as shown in Table 4.
Table 4.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14 Days | Control group | 192.48 ± 8.39 | 207.30 ± 13.79 | 192.97 ± 9.36 |
300 mg/kg group | 181.27 ± 7.41 | 191.63 ± 9.46 | 184.44 ± 10.46 | |
600 mg/kg group | 178.50 ± 8.56 * | 187.36 ± 12.34 * | 189.46 ± 6.35 | |
900 mg/kg group | 175.76 ± 7.44 * | 181.57 ± 9.75 ** | 175.28 ± 8.72 * | |
28 Days | Control group | 197.38 ± 11.73 | 210.22 ± 13.95 | 197.81 ± 8.70 |
300 mg/kg group | 189.57 ± 2.21 * | 192.58 ± 8.20 * | 179.18± 10.47 * | |
600 mg/kg group | 179.43 ± 8.32 ** | 184.32 ± 8.53 ** | 172.11 ± 10.59 ** | |
900 mg/kg group | 180.07 ± 6.65 ** | 173.95 ± 6.45 ** | 164.77 ± 7.68 ** | |
42 Days | Control group | 217.46 ± 4.83 | 208.55 ± 13.49 | 195.62 ± 9.49 |
300 mg/kg group | 206.67 ± 8.83 * | 181.51 ± 6.52 ** | 179.13 ± 5.47 ** | |
600 mg/kg group | 202.10 ± 6.21 ** | 169.98 ± 14.29 ** | 175.82 ± 9.69 ** | |
900 mg/kg group | 198.45 ± 6.41 ** | 175.86 ± 10.98 ** | 170.76 ± 4.30 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
3.5. Changes of the GSH Contents
The GSH contents of duodenum and jejunum were markedly (p < 0.05 or p < 0.01) lower in the 300, 600 and 900 mg/kg groups than those in the control group from 14 to 42 days of age. The ileac GSH content was reduced (p < 0.05) in the 300 mg/kg group and significantly (p < 0.05 or p < 0.01) reduced in the 600 and 900 mg/kg groups when compared with that of the control group from 14 to 42 days of age (Table 5).
Table 5.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14.Days | Control group | 7.06 ± 0.75 | 5.47 ± 0.47 | 2.66 ± 0.31 |
300 mg/kg group | 6.84 ± 0.56 | 5.07 ± 0.46 | 2.30 ± 0.16 | |
600 mg/kg group | 7.07 ± 0.35 | 4.43 ± 0.28 ** | 2.74 ± 0.55 | |
900 mg/kg group | 6.10 ± 0.49 * | 4.10 ± 0.30 ** | 2.08 ± 0.16 * | |
28 Days | Control group | 7.06 ± 0.75 | 4.57 ± 0.23 | 2.60 ± 0.25 |
300 mg/kg group | 6.24 ± 0.34 * | 3.69 ± 0.38 ** | 1.89 ± 0.46 * | |
600 mg/kg group | 6.06 ± 0.59 ** | 3.55 ± 0.36 ** | 1.95 ± 0.14 ** | |
900 mg/kg group | 5.47 ± 0.20 ** | 2.96 ± 0.17 ** | 1.63± 0.41 ** | |
42 Days | Control group | 6.35 ± 0.37 | 4.57 ± 0.41 | 3.15 ± 0.21 |
300 mg/kg group | 5.48 ± 0.43 ** | 3.58 ± 0.25 ** | 2.58 ± 0.40 * | |
600 mg/kg group | 5.68 ± 0.28 * | 3.25 ± 0.34 ** | 2.38 ± 0.17 ** | |
900 mg/kg group | 4.92±0.32 ** | 3.45±0.41 ** | 1.95 ± 0.40 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
3.6. Changes of the MDA Contents
The MDA contents of duodenum and jejunum were increased (p < 0.05) in the 300 mg/kg group and markedly (p < 0.05 or p < 0.01) increased in the 600 and 900 mg/kg groups in comparison with those of the control group from 14 to 42 days of age. The ileac MDA content was higher (p < 0.05 or p < 0.01) in the 300, 600 and 900 mg/kg groups than that in the control group from 14 to 42 days of age (Table 6).
Table 6.
Days | Groups | Duodenum | Jejunum | Ileum |
---|---|---|---|---|
14 Days | Control group | 2.32 ± 0.04 | 2.20 ± 0.09 | 2.67 ± 0.33 |
300 mg/kg group | 2.47 ± 0.09 | 2.37 ± 0.14 | 3.06 ± 0.18 | |
600 mg/kg group | 2.42 ± 0.25 | 2.48 ± 0.30 | 3.04 ± 0.19 | |
900 mg/kg group | 2.61 ± 0.20 * | 2.56 ± 0.20 * | 2.97 ± 0.29 | |
28 Days | Control group | 1.99 ± 0.39 | 2.30 ± 0.15 | 2.07 ± 0.29 |
300 mg/kg group | 2.65 ± 0.22 * | 2.93 ± 0.23 * | 2.66 ± 0.33 * | |
600 mg/kg group | 2.79 ± 0.38 ** | 3.13 ± 0.49 ** | 3.09 ± 0.55 ** | |
900 mg/kg group | 3.03 ± 0.26 ** | 3.56 ± 0.47 ** | 3.30 ± 0.17 ** | |
42 Days | Control group | 2.01 ± 0.48 | 2.66 ± 0.27 | 2.62 ± 0.35 |
300 mg/kg group | 2.79 ± 0.42 * | 3.29 ± 0.30 * | 3.46 ± 0.59 * | |
600 mg/kg group | 3.27 ± 0.39 ** | 3.82 ± 0.48 ** | 3.50 ± 0.22 * | |
900 mg/kg group | 3.41 ± 0.46 ** | 3.65 ± 0.49 ** | 4.12 ± 0.60 ** |
Data are presented with the means ± standard deviation (n = 5); * p < 0.05, compared with the control group, ** p < 0.01, compared with the control group; Data were analyzed by variance analysis using SPSS 16.0 software.
4. Discussion
Though Ni is an essential element and its biological actions are not fully understood, it has been proved that its chemical transformations within cells lead to the production of reactive forms of oxygen [27,28]. Some studies have been shown that Ni enhances the oxidation of all DNA bases in vitro [29] and lipid peroxidation in vivo [30]. The incubation of Ni with cysteine in an aerobic environment generates hydroxyl radicals, which then react with cysteine to generate carbon-centered alkyl radicals. Free radicals can also be generated from lipid hydroperoxides by Ni in the presence of several oligopeptides [31,32]. Misra et al. [23] showed that a single intraperitoneal injection of nickel acetate decreased CAT, GSH-Px, GSSG-R activities and GSH concentration, and increased the MDA content, and the activity of SOD were not significantly decreased in rat liver and kidney. However, nickel had no effect on CAT and GSH-Px activities in blood. Sunderman et al. [33] also showed that MDA concentrations were significantly increased in the liver and kidney of rats. In agreement with results of the abovementioned studies, our data suggested that dietary NiCl2 caused the intestinal oxidative damage in broilers, which showed a dose and time dependent increase of MDA contents, and decrease of GSH-Px, SOD, CAT activities and GSH contents, ability to inhibit hydroxy radical in the intestines (duodenum, jejunum and ileum). The same results were observed in the serum oxidative stress in broilers fed on diets supplemented with NiCl2 in our early studies [34].
The intestinal mucosa is vulnerable to oxidative damage due to the constant exposure to ROS generated by the luminal contents, e.g., oxidized food, transition metals and salivary oxidants [19]. If this oxidative condition proceeds in intestinal cells for an extended period, injuries may occur due to the accumulation of lipid peroxides [35]. It is well known that enhanced ROS generation can overwhelm cell’s intrinsic antioxidant defenses and result in a condition known as “oxidative stress” [36]. Endogenous antioxidants have the capability to prevent the uncontrolled formation of reactive oxygen negative ion. These antioxidants mainly include antioxidant enzymes and non-enzymatic antioxidants [37]. Antioxidant enzymes, such as SOD and CAT, are considered to be the first line of cellular defense against oxidative damage [38]. SOD must work together with antioxidant enzymes, namely GSH-Px and catalase, which remove hydrogen peroxide [39]. In the present study, the activities of antioxidant enzymes including SOD, CAT and GSH-Px in the intestines were all decreased in the 300, 600 and 900 mg/kg groups when compared with those of the control group (Table 1, Table 2, Table 3). The decreased activities of the abovementioned enzymes can lead to an excessive availability of superoxide and hydrogen peroxide in biological systems, which in turn will generate hydroxyl radicals involved in initiation and propagation of lipid peroxidation [40]. In the present study, it was found that the ability to inhibit hydroxy radical in intestines was decreased in the 300, 600 and 900 mg/kg groups when compared with those of control group (Table 4), implying that excess hydroxy radicals accumulated in the intestinal mucosa. Furthermore, hydroxy radical is one of the major oxygen radicals that can cause oxidative stress. Low levels of antioxidant enzyme activities and high levels of free radicals lead to the development of oxidative damage in the intestines.
Among non-enzymatic antioxidants, glutathione (GSH) plays a primary role and is regarded as an early biological marker of the oxidative stress [41]. In the present study, the GSH content was significantly reduced in the 300, 600 and 900 mg/kg groups from 14 to 42 days of age (Table 5). The reduced glutathione (GSH) was an important cellular antioxidant because of high intracellular concentration and also serves as a substratum of essential scavenger enzymes to maintain oxidative balance [42]. The decreased GSH-Px activity may also be due to the reduced availability of GSH in the present study.
In addition, the intestinal oxidative damage induced by dietary NiCl2 in the present study was also associated with the increased level of lipid peroxidation as measured by MDA production (Table 6). Our data are in agreement with the studies of Sunderman et al. [43] that the level of MDA is found to be significantly elevated in serum of NiCl2-treated rats. MDA is one of several low-molecular-weight end products that are formed via the decomposition of certain primary and secondary lipid peroxidation products [44]. The MDA production induces alteration of membrane fluidity and increase of membrane fragility [40,45]. Moreover, MDA inhibits various enzyme reactions and exerts mutagenicity and carcinogenicity by forming DNA adducts [46]. High levels of MDA contents imply the enhancement of lipid peroxidation and accumulation of lipid peroxides in the intestinal mucosa, the generation of the reactive species in this condition causes significant the reversible or irreversible oxidative damage to a wide range of biological molecules including DNA, lipids, proteins, carbohydrates or any nearby molecule causing a cascade of chain reactions resulting in intestinal cellular damage.
5. Conclusions
According to the results of the present study and the aforementioned discussion, it is concluded that dietary NiCl2 in excess of 300 mg/kg causes inhibition of antioxidant enzyme activities, enhancement of lipid peroxidation and accumulation of free radicals, which consequently induces oxidative damage in the intestinal mucosa of broilers. The intestinal functions including absorptive function and mucosal immune function are finally impaired due to the oxidative damage of the intestinal mucosa. The oxidative damage may be a main mechanism on the effects of NiCl2 on the intestinal health.
Acknowledgments
Bangyuan Wu and Hengmin Cui designed the research; Bangyuan Wu, Xi Peng, Jing Fang, Zhicai Zuo, Junliang Deng and Jianying Huang performed the research; Bangyuan Wu analyzed the data; Bangyuan Wu wrote the paper. The study was supported by the program for Changjiang Scholars and Innovative University Research Teams (IRT 0848) and the Education Department (09ZZ017) and Scientific Department of Sichuan Province.
Conflict of Interest
The authors declare no conflict of interest. Our experiments involving the use of broilers, and the use of chickens and all experimental procedures involving animals were approved by Sichuan Agricultural University Animal Care and Use Committee.
References
- 1.Cempel M., Nikel G. Nickel: A review of its sources and environmental toxicology. Pol. J. Environ. Stud. 2006;15:375–382. [Google Scholar]
- 2.Anke M., Grun M., Ditrich G., Groppel B., Hennig A. Low Nickel Rations for Growth and Reproduction in Pigs. In: Hoekstra W.G., Suttle J.W., Canther H.E., Mertz W., editors. Trace Element Metabolism in Animals-2. University Park Press; Baltimore, MD, USA: 1974. pp. 715–718. [Google Scholar]
- 3.Nielsen F.H., Myron D.R., Givand S.H., Zimmerman T.J., Ollerich D.A. Nickel deficiency in rats. J. Nutr. 1975;105:1620–1630. doi: 10.1093/jn/105.12.1620. [DOI] [PubMed] [Google Scholar]
- 4.Afridi H.I., Kazi T.G., Kazi N., Sirajuddin, Kandhro G.A., Baig J.A., Shah A.Q., Wadhwa S.K., Khan S., Kolachi N.F., Shah F., Jamali M.K., Arain M.B. valuation of status of cadmium, lead, and nickel levels in biological samples of normal and night blindness children of age groups 3–7 and 8–12 years. Biol. Trace Elem. Res. 2011;142:350–361. doi: 10.1007/s12011-010-8796-9. [DOI] [PubMed] [Google Scholar]
- 5.Stangl G.I., Kirchgessner M. Nickel deficiency alters liver lipid metabolism in rats. J. Nutr. 1996;126:2466–2473. doi: 10.1093/jn/126.10.2466. [DOI] [PubMed] [Google Scholar]
- 6.Nielsen F.H., Uthus E.O., Poellot R.A., Shuler T.R. Dietary vitamin B12, sulfur amino acids, and oddchain fatty acids affect the responses of rats to nickel deprivation. Biol. Trace Elem. Res. 1993;37:1–15. doi: 10.1007/BF02789397. [DOI] [PubMed] [Google Scholar]
- 7.Uthus E.O., Poellot R.A. Dietary nickel and folic acid interact to affect folate and methionine metabolism in the rat. Biol. Trace Elem. Res. 1997;58:25–33. doi: 10.1007/BF02910663. [DOI] [PubMed] [Google Scholar]
- 8.Ray W.J., Goodin D.S., Ng L. CobaIt(II) and nickel(II) complexes of phosphoglucomutase. Biochemistry. 1972;11:2800–2804. doi: 10.1021/bi00765a011. [DOI] [PubMed] [Google Scholar]
- 9.Jolly P.W., Wilke G. the Organic Chemistry of Nickel. Academic Press; New York, NY, USA: 1974. Organonickel Complexes. [Google Scholar]
- 10.Dixon N.E., Gazzola C., Blakely R.L., Zerner B. Metal ions in enzymes using ammonia or amides. Science. 1976;191:1144–1150. doi: 10.1126/science.769157. [DOI] [PubMed] [Google Scholar]
- 11.Fishbein W.N., Smith M.J., Nagarajano K., Scurzi W. Federation Proceedings; Berkeley, CA, USA: University of California Press; [Google Scholar]
- 12.Polacco J.C. Nitrogen metabolism in soybean tissue culture II. Urea utilization and urease synthesis require Ni2+ Am. Soc. Plant Biol. 1997;59:827–830. doi: 10.1104/pp.59.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Diekert G., Thauer R.K. The effect of nickel on carbon monoxide dehydrogenase formation in Clostridium thermoaceticum and Clostridiurnformicoaceticum. FEMS Microbiol. Lett. 1980;7:187–189. doi: 10.1111/j.1574-6941.1980.tb01622.x. [DOI] [Google Scholar]
- 14.Diekert G., Weber B., Thauer R.K. Nickel dependence of factor F430 content in Methanobacterium thermoautotrophicum. Arch. Microbiol. 1980;127:273–277. doi: 10.1007/BF00427204. [DOI] [PubMed] [Google Scholar]
- 15.Drake H.L., Hu S.I., Wood H.G. Purification of carbon monoxide dehydrogenase, a nickel enzyme from Clostridium thermoaceticum. J. Biol. Chem. 1980;255:7174–7180. [PubMed] [Google Scholar]
- 16.IARC . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding. WHO International Agency for Research on Cancer; Lyon, France: 1990. [PMC free article] [PubMed] [Google Scholar]
- 17.Das K.K., Das S.N., Dhundasi S.A. Nickel, its adverse health effects & oxidative stress. Indian J. Med. Res. 2008;128:412–425. [PubMed] [Google Scholar]
- 18.Nielsen F.H., Myron D.R., Givand S.H., Ollerich D.A. Nickel deficiency and nickel-rhodium interaction in chicks. J. Nutr. 1975;105:1607–1619. doi: 10.1093/jn/105.12.1607. [DOI] [PubMed] [Google Scholar]
- 19.Deitch E.A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch. Surg. 1990;125:403–413. doi: 10.1001/archsurg.1990.01410150125024. [DOI] [PubMed] [Google Scholar]
- 20.Halliwell B., Zhao K., Whiteman M. The gastrointestinal tract: A major site of antioxidant action. Free Radic. Res. 2000;33:819–830. doi: 10.1080/10715760000301341. [DOI] [PubMed] [Google Scholar]
- 21.Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 1995;41:1819–1828. [PubMed] [Google Scholar]
- 22.Das K.K., Buchner V. Effect of nickel exposure on peripheral tissues: Role of oxidative stress in toxicity and possible protection by ascorbic acid. Rev. Environ. Health. 2007;22:133–149. doi: 10.1515/reveh.2007.22.2.157. [DOI] [PubMed] [Google Scholar]
- 23.Misra M., Rodriguez R.E., Kasprzak K.S. Nickel induced lipid peroxidation in the rat: Correlation with nickel effect on antioxidant defense systems. Toxicology. 1990;64:1–17. doi: 10.1016/0300-483X(90)90095-X. [DOI] [PubMed] [Google Scholar]
- 24.National Research Council (NRC) Nutrient Requirements of Poultry. National Academy Press; Washington, DC, USA: 1994. [Google Scholar]
- 25.Shirkey R.J., Chakraborty J., Bridges J.W. An improved method for preparing rat small intestine microsomal fractions for studying drug metabolism. Anal. Biochem. 1979;93:73–81. doi: 10.1016/S0003-2697(79)80118-9. [DOI] [PubMed] [Google Scholar]
- 26.Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- 27.Kawanishi S., Inoue S., Yamamoto K. Active oxygen species in DNA damage induced by carcinogenic metal compounds. Environ. Health Perspect. 1994;102:17–20. doi: 10.1289/ehp.94102s317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Novelli E.L., Rodrigues N.L., Ribas B.O. Superoxide radical and toxicity of environmental nickel exposure. Hum. Exp. Toxicol. 1995;14:248–251. doi: 10.1177/096032719501400303. [DOI] [PubMed] [Google Scholar]
- 29.Salnikow K., Gao M., Voitkun V., Huang X., Costa M. Altered oxidative stress responses in nickel-resistant mammalian cells. J. Canc. Res. 1994;54:6407–6412. [PubMed] [Google Scholar]
- 30.Coogan T.P., Latta D.M., Snow E.T., Costa M., Lawrence A. Toxicity and carcinogenicity of nickel compounds. Crit. Rev. Toxicol. 1989;19:341–384. doi: 10.3109/10408448909029327. [DOI] [PubMed] [Google Scholar]
- 31.Chen C.Y., Huang Y.F., Lin Y.H., Yen S.F. Nickel-induced oxidative stress and effect of antioxidants in human lymphocytes. Arch. Toxicol. 2003;77:123–130. doi: 10.1007/s00204-002-0427-6. [DOI] [PubMed] [Google Scholar]
- 32.Chen C.Y., Huang Y.F., Huang W.R., Huang Y.T. Nickel induces oxidative stress and genotoxicity in human lymphocytes. Toxicol. Appl. Pharmacol. 2003;189:153–159. doi: 10.1016/S0041-008X(03)00086-3. [DOI] [PubMed] [Google Scholar]
- 33.Sunderman F.W., Jr., Marzouk A., Hopfer S.M., Zaharia O., Reid M.C. Increased lipid peroxidation in tissues of nickel chloride treated rats. Ann. Clin. Lab. Sci. 1985;15:229–236. [PubMed] [Google Scholar]
- 34.Wu B.Y., Cui H.M., Peng X., Fang J., Zuo Z.C., Deng J.L., Huang J.Y. Investigation of the serum oxidative stress in broilers fed on diets supplemented with nickel chloride. Health. 2013;5:454–459. doi: 10.4236/health.2013.53061. [DOI] [Google Scholar]
- 35.Ercal N., Gurer-Orhan H., Aykin-Burns N. Toxic metals and oxidative stress part I: Mechanisms involved in metal induced oxidative damage. Curr. Top. Med. Chem. 2001;1:529–539. doi: 10.2174/1568026013394831. [DOI] [PubMed] [Google Scholar]
- 36.Halliwell B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007;35:1147–1150. doi: 10.1042/BST0351147. [DOI] [PubMed] [Google Scholar]
- 37.Adedara I.A., Owumi S.E., Uwaifo A.O., Farombi E.O. Aflatoxin B1 and ethanol co-exposure induces hepatic oxidative damage in mice. Toxicol. Ind. Health. 2010;26:717–724. doi: 10.1177/0748233710377772. [DOI] [PubMed] [Google Scholar]
- 38.Ferreccio C., Gonzalez P.C., Milosavjlevic S.V., Marshall G.G., Maria S.A. Lung cancer and arsenic exposure in drinking water: A case control study in northern Chile. Cad. Saude. Publica. 1998;14:193–198. doi: 10.1590/S0102-311X1998000100028. [DOI] [PubMed] [Google Scholar]
- 39.Naziroglu M. Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem. Res. 2009;34:2181–2191. doi: 10.1007/s11064-009-0015-8. [DOI] [PubMed] [Google Scholar]
- 40.Naziroglu M. Molecular role of catalase on oxidative stress-induced Ca2+ signaling and TRP cation channel activation in nervous system. J. Recept. Signal. Transduct. Res. 2012;32:134–141. doi: 10.3109/10799893.2012.672994. [DOI] [PubMed] [Google Scholar]
- 41.Gagliano N., Dalle I.D., Torri C., Miglioric M., Grizzid F., Milzanib A., Filippic C., Annonie G., Colombof P., Costaa F., et al. Early cytotoxic effects of Ochratoxin A in rat liver: A morphological, biochemical and molecular study. Toxicology. 2006;225:214–224. doi: 10.1016/j.tox.2006.06.004. [DOI] [PubMed] [Google Scholar]
- 42.Aw T.Y. Intestinal glutathione: Determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol. Appl. Pharmacol. 2005;204:320–328. doi: 10.1016/j.taap.2004.11.016. [DOI] [PubMed] [Google Scholar]
- 43.Sunderman F.W., Jr., Dingle B., Hopfer S.M., Swift T. Acute nickel toxicity in electroplating workers who accidentally ingested a solution of nickel sulphate and nickel chloride. Amer. J. Ind. Med. 1988;14:257–266. doi: 10.1002/ajim.4700140303. [DOI] [PubMed] [Google Scholar]
- 44.Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol. Med. 1990;9:515–540. doi: 10.1016/0891-5849(90)90131-2. [DOI] [PubMed] [Google Scholar]
- 45.Chen J.J., Yu B.P. Alteration in mitochondrial membrane fluidity by lipid peroxidation products. Free Radical Biol. Med. 1994;17:411–418. doi: 10.1016/0891-5849(94)90167-8. [DOI] [PubMed] [Google Scholar]
- 46.Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 1999;424:83–95. doi: 10.1016/S0027-5107(99)00010-X. [DOI] [PubMed] [Google Scholar]